BROOKS LABORATORIES Financial Statement Analysis
|
||
The Revenues of BROOKS LABORATORIES have decreased by -30.68% YoY .
The Earnings Per Share (EPS) of BROOKS LABORATORIES has decreased by Negative YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
BROOKS LABORATORIES Last 5 Annual Financial Results
[BOM: 533543|NSE : BROOKS]
Consolidated | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
---|---|---|---|---|
Revenues | ₹63 Cr | ₹91 Cr | ₹77 Cr | ₹77 Cr |
Expenses | ₹90 Cr | ₹105 Cr | ₹77 Cr | ₹77 Cr |
Operating Profit (Excl OI) | ₹-26 Cr | ₹-14 Cr | ₹0.52 Cr | ₹0.52 Cr |
Other Income | ₹0.21 Cr | ₹0.80 Cr | ₹0.74 Cr | ₹0.74 Cr |
Interest | ₹2.18 Cr | ₹3.10 Cr | ₹3.10 Cr | ₹3.10 Cr |
Depreciation | ₹7.03 Cr | ₹7.35 Cr | ₹7.14 Cr | ₹7.14 Cr |
Profit Before Tax | ₹-38 Cr | ₹-24 Cr | ₹-8.99 Cr | ₹-8.99 Cr |
Profit After Tax | ₹-31 Cr | ₹-19 Cr | ₹-19 Cr | ₹-19 Cr |
Consolidated Net Profit | ₹-21 Cr | ₹-11 Cr | ₹-19 Cr | ₹-19 Cr |
Earnings Per Share (Rs) | ₹-7.46 | ₹-8.46 | ₹-4.57 | ₹-7.84 |
PAT Margin (%) | -24.65 | -49.12 | -21.18 | -25.08 |
ROE(%) | -28.08 | -38.46 | -23.18 | -24.48 |
ROCE(%) | -24.92 | -37.83 | -18.72 | -5.33 |
Total Debt/Equity(x) | 0.08 | 0.08 | 0.28 | 0.40 |
Key Financials |
||
Market Cap | : | ₹ 405.6 Cr |
Revenue (TTM) | : | ₹ 100.5 Cr |
Net Profit(TTM) | : | ₹ 2.8 Cr |
EPS (TTM) | : | ₹ 0.9 |
P/E (TTM) | : | 146.0 |
Industry Peers & Returns | 1W | 1M | 1Y |
BROOKS LABORATORIES | -7.7% | -1.8% | 61.3% |
SUN PHARMACEUTICAL INDUSTRIES | -0% | -0.4% | 10.2% |
DIVIS LABORATORIES | 1.4% | 4.1% | 50.3% |
CIPLA | 0.5% | 1.6% | 1.4% |
TORRENT PHARMACEUTICALS | -1.2% | 7.1% | 18.3% |
DR REDDYS LABORATORIES | 1.7% | 1.2% | 1.5% |
MANKIND PHARMA | 5% | 3.3% | 11% |
ZYDUS LIFESCIENCES | 1.2% | 4.8% | -7% |
LUPIN | 2% | -0.9% | 19.8% |
BROOKS LABORATORIES Revenues
[BOM: 533543|NSE : BROOKS]
Y-o-Y | -30.68 % |
5 Yr CAGR | -6.47 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2024 | ₹63 Cr | -30.68 | |
Mar2023 | ₹91 Cr | 18.04 | |
Mar2022 | ₹77 Cr | 0.00 | |
Mar2021 | ₹77 Cr | - |
BROOKS LABORATORIES Operating Profit
[BOM: 533543|NSE : BROOKS]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹-26 Cr | Negative | |
Mar2023 | ₹-14 Cr | Negative | |
Mar2022 | ₹0.52 Cr | 0.00 | |
Mar2021 | ₹0.52 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2024 | -41.8% | Negative | |
Mar2023 | -15.63% | Negative | |
Mar2022 | 0.67% | 0.00 | |
Mar2021 | 0.67% | - |
BROOKS LABORATORIES Profit After Tax
[BOM: 533543|NSE : BROOKS]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹-21 Cr | Negative | |
Mar2023 | ₹-11 Cr | Negative | |
Mar2022 | ₹-19 Cr | Negative | |
Mar2021 | ₹-19 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2024 | -24.65 % | Negative | |
Mar2023 | -49.12 % | Negative | |
Mar2022 | -21.18 % | Negative | |
Mar2021 | -25.08 % | - |
BROOKS LABORATORIES Earnings Per Share (EPS)
[BOM: 533543|NSE : BROOKS]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | EPS | % Change | |
---|---|---|---|
Mar2024 | ₹-7.46 | Negative | |
Mar2023 | ₹-8.46 | Negative | |
Mar2022 | ₹-4.57 | Negative | |
Mar2021 | ₹-7.84 | - |
BROOKS LABORATORIES Return on Capital Employed (ROCE)
[BOM: 533543|NSE : BROOKS]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | ROCE | % Change | |
---|---|---|---|
Mar2024 | -24.92% | Negative | |
Mar2023 | -37.83% | Negative | |
Mar2022 | -18.72% | Negative | |
Mar2021 | -5.33% | - |
BROOKS LABORATORIES Share Price vs Sensex
Current Share Price | : | ₹137.5 |
Current MarketCap | : | ₹ 405.6 Cr |
Updated EOD on | : | Jul 04,2025 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BROOKS LABORATORIES | -7.7% |
-1.8% |
61.3% |
SENSEX | -0.7% |
3% |
5% |
BROOKS LABORATORIES related INDICES
You may also like the below Video Courses
FAQ about BROOKS LABORATORIES Financials
How the annual revenues of BROOKS LABORATORIES have changed ?
The Revenues of BROOKS LABORATORIES have decreased by -30.68% YoY .
How the Earnings per Share (EPS) of BROOKS LABORATORIES have changed?
The Earnings Per Share (EPS) of BROOKS LABORATORIES has decreased by Negative YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs